Table 2

Baseline characteristics of study participants with and without incident atrial fibrillation at baseline examination

All subjects n=1599Subjects without incident AF n=1321Subjects with incident AF n=278P value
Age (years)67.3 (±6.0)66.8 (±6.0)69.7 (±5.3)<0.001
Sex (n female (%)) 475 (29.7) 401 (30.4) 74 (26.6)0.205
Smoking (n (%)) 287 (17.9) 244 (18.5) 43 (15.5)0.661
AHT (%) 714 (44.7) 552 (41.8) 162 (58.3)<0.001
BMI (kg/m2)28.3 (±4.3)28.0 (±4.2)29.5 (±4.9)<0.001
SBP (mm Hg)147.1 (±20.2)147.1 (±20.2)147.2 (±20.3)0.959
Prevalent diabetes (n (%)) 639 (40.0) 500 (37.9) 139 (50.0)<0.001
Prevalent CVD (n (%)) 156 (9.8) 116 (8.8) 40 (14.4)0.004
Prevalent HF (n (%)) 16 (1.0) 11 (0.8) 5 (1.8)0.081
  • Values are displayed as means (±SD) or, for skewed variables, medians and IQR (25–75).

  • AF, atrial fibrillation; AHT, antihypertensive treatment; BMI, body mass index; CVD, cardiovascular disease; HF, heart failure; SBP, systolic blood pressure.